Fundraising FoxEsperovax
Plymouth, US · 2 known investors
Find your way into Esperovax
Sign up to see every warm intro you have to Esperovax
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Esperovax team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.
Founders & leadership
RN
Roger Newton
SN
Savita Nikam
DO
David O'HaganCo-founder, President, and CEO
Investors · 2
Michigan Rise✓ confirmed by EsperovaxEast Lansing · $50K – $150K
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Esperovax do?
- Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.
- Who are Esperovax's investors?
- Esperovax's investors include Michigan Rise, ID Ventures.
- Where is Esperovax headquartered?
- Esperovax is headquartered in Plymouth, US.